Bayer AG Media Conference Call

Bayer grows sales and earnings significantly

• Group sales rise by 14.3 percent (Fx & portfolio adj.) to 9.781 billion euros
• EBITDA before special items increases by 16.4 percent to 2.089 billion euros
• Crop Science reports strong increase in sales and earnings
• Pharmaceuticals and Consumer Health again post considerable sales growth
• Core earnings per share advance by 29.6 percent to 1.05 euros
• Net income at 85 million euros
• Free cash flow remains strong at 1.954 billion euros
• Revised outlook confirms good business performance